Thigh Injections of Cabotegravir + Rilpivirine in Virally Suppressed Adults With Human Immunodeficiency Virus Type 1: A Substudy of the Phase 3b ATLAS-2M Study

0
11
Investigators presented substudy results on short-term repeat intramuscular cabotegravir + rilpivirine long-acting thigh injections in participants with ≥3 years of experience with gluteal administration during the ATLAS–2M study.
[Clinical Infectious Diseases]
Full Article